PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Michael Millward, MD
Sir Charles Gairdner Hospital - Nedlands
Study Chair - Penny Bradbury, MD
NCIC Clinical Trials Group
Study Chair - Peter Ellis, MD
Margaret and Charles Juravinski Cancer Centre
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
89 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cer - Instituto Medico
Buenos Aires, B1878dvb Bs. As., Argentina
- Coiba Centro de Oncologia E Investigacion
Berazategui, Buenos Aires, Argentina
- Damic-Fundacion Rusculleda
Córdoba, Argentina
- Centro Medico San Roque
San Miguel de Tucumán, Argentina
- Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
- Concord Repatriation General Hospital
Concord, New South Wales, Australia
- St. George Hospital, Cancer Care Centre
Kogarah, New South Wales, Australia
- Prince of Wales Hospital
Randwick, New South Wales, Australia
- Royal North Shore Hospital
St Leonards, New South Wales, Australia
- Calvary Mater Newcastle Hospital
Waratah, New South Wales, Australia
- Westmead Hospital
Westmead, New South Wales, Australia
- the Prince Charles Hospital
Chermside, Queensland, Australia
- Nambour General Hospital
Nambour, Queensland, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Monash Medical Centre
Clayton, Victoria, Australia
- Western Hospital
Footscray, Victoria, Australia
- Frankston Hospital - Peninsula Oncology Centre
Frankston, Victoria, Australia
- Geelong Hospital
Geelong, Victoria, Australia
- Austin Hospital
Heidelberg, Victoria, Australia
- Sir Charles Gairdner Hospital
Perth, Western Australia, Australia
- Centro de Oncologia E Radioterapia (cor) Mae de Deus
Porto Alegre, Rio Grande do Sul, Brazil
- Fundacao Pio Xii - Hospital de Cancer de Barretos
Barretos, São Paulo, Brazil
- Esho - Empresa de Servicos Hospitalares Ltda.
Brasilia, São Paulo, Brazil
- Centro de Pesquisa Clinica Do Hospital
Porto Alegre, São Paulo, Brazil
- Oxion Hospital Dia Oncologia Ltda - Oxion
Belo Horizonte, Brazil
- Facility name not stated
Centro, Brazil
- Nucleo de Oncologia Da Bahia
Salvador, Brazil
- Gram - Grupo de Assistencia Medica
São Paulo, Brazil
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Bcca - Abbotsford Centre
Abbotsford British Columbia, British Columbia, Canada
- Bcca - Fraser Valley Cancer Centre
Surrey, British Columbia, Canada
- Bcca - Vancouver Cancer Centre
Vancouver, British Columbia, Canada
- Atlantic Health Sciences Corporation
Saint John, New Brunswick, Canada
- Dr. H. Bliss Murphy Cancer Centre
St. John's, Newfoundland and Labrador, Canada
- Qeii Health Sciences Centre
Halifax, Nova Scotia, Canada
- Health Sciences North
Greater Sudbury, Ontario, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Cancer Centre of Southeastern Ontario at Kingston
Kingston, Ontario, Canada
- London Regional Cancer Program
London, Ontario, Canada
- Lakeridge Health Oshawa
Oshawa, Ontario, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Dec 2009
- Primary completion
- 15 Jan 2014
- Completion
- 27 Nov 2015
- Last update posted
- 22 Aug 2023
- Registered enrollment
- 720
- Registry id
- NCT01000025
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.